{"database": "lobbying", "table": "lobbying_activities", "rows": [[1732916, "1090f700-f9d1-42a5-a023-0402dd41fa41", "Q3", "NELSON MULLINS RILEY & SCARBOROUGH", 285871, "HEMOPHILIA OF GEORGIA", 2015, "third_quarter", "PHA", "Issues related to implementation of the ACA, Hemophilia research and treatments, and the 340B Drug Pricing Program", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2015-10-16T08:37:58.327000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1732916"], "units": {}, "query_ms": 0.3501759492792189, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}